AbCellera Biologics Inc vs Google Inc — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while Google Inc trades at $344.75 (market cap $4.20T). The key difference: Google Inc is far larger — about 1404.7× AbCellera Biologics Inc's market cap, and Google Inc pays a 0.26% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | GOOG | |
|---|---|---|
Market Cap | $2.99B | $4.20T |
Sector | Health | Technology |
52-Week High | $9.76 | $399.06 |
52-Week Low | $2.78 | $200.19 |
Enterprise Value | $2.58B | $4.09T |
Volume | — | 1,511,127 |
Dividend Yield | — | 0.26% |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.
Read more on GOOG →